Physiologic Pacing Registry
1 other identifier
observational
870
15 countries
49
Brief Summary
The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomical map of cardiac structures prior to physiologic pacing device implants based on the clinical site's routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2018
Typical duration for all trials
49 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2018
CompletedFirst Posted
Study publicly available on registry
October 25, 2018
CompletedStudy Start
First participant enrolled
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2021
CompletedResults Posted
Study results publicly available
August 19, 2024
CompletedAugust 19, 2024
August 1, 2024
2.9 years
October 23, 2018
April 25, 2023
August 15, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Physiologic Pacing Implant Success Rate
849 subjects underwent attempted implants of physiologic pacing leads. Implant success rate was based on investigator-reported outcome.
During procedure
Pacing Capture Threshold for His Bundle Pacing
The pacing capture threshold was collected to characterize electrical performance in the Bundle of His area at 6 months. Pacing capture threshold is the minimum amount of voltage (V) needed to depolarize the myocardium or heart muscle with an electrical impulse from a pacemaker, ICD, or CRT.
6 Months
Interventions
An alternative and potentially more effective pacing strategy for patients with electrical conduction abnormalities is physiologic pacing. Physiologic pacing is achieved by delivering a pacing stimulus to a cardiac conduction structure, such as the bundle of His or left bundle branch (LBB) of the His-Purkinje system, with a permanent lead. Physiologic pacing activates the heart through the native His-Purkinje conduction system, thus offering the most physiologic pacing approach to correct electrical dyssynchrony. Physiologic pacing has emerged as a feasible and safe alternative to pacemaker therapy and CRT with clinical and electrophysiological advantages.
Eligibility Criteria
The registry will include patients undergoing implantation of a pacemaker, defibrillator, or a cardiac resynchronization therapy (CRT) pacemaker (CRT-P) or CRT defibrillator (CRT-D) according to the clinical site's routine care.
You may qualify if:
- Scheduled for implantation of an Abbott pacemaker, defibrillator, or CRT-P/D device with any commercially available pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care.
- At least 18 years of age.
- Willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
- Provided written informed consent prior to any registry-related procedures.
You may not qualify if:
- History of tricuspid valve repair or replacement.
- Currently participating in another clinical study with an active treatment arm and belong to the active arm
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results.
- Chronic physiologic pacing lead implanted
- Life expectancy of \< 6 months.
- Known contraindication for physiologic pacing therapy/implant (i.e. ongoing infection, known occlusion of the subclavian vein, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (50)
Heart Center Research, LLC.
Huntsville, Alabama, 35801, United States
Mills-Peninsula Medical Center
Burlingame, California, 94010, United States
University of California at San Diego (UCSD) Medical Center
San Diego, California, 92103, United States
Yoel R. Vivas, MD
Delray Beach, Florida, 33484, United States
Usman R. Siddiqui, MD
Winter Park, Florida, 32792, United States
Rush University Medical Center
Chicago, Illinois, 60612, United States
University of Chicago
Chicago, Illinois, 60637, United States
IU Health Bloomington Hospital
Bloomington, Indiana, 47403, United States
Iowa Heart Center
West Des Moines, Iowa, 50266, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Charlton Memorial Hospital
Fall River, Massachusetts, 02720, United States
Providence Hospital
Southfield, Michigan, 48075, United States
The Valley Hospital
Ridgewood, New Jersey, 07450, United States
New Mexico Heart Institute
Albuquerque, New Mexico, 87102, United States
New York University Hospital
New York, New York, 10016, United States
Duke University Medical Center
Durham, North Carolina, 27705, United States
Providence Heart & Vascular Institute
Portland, Oregon, 97225, United States
Geisinger Medical Center
Danville, Pennsylvania, 17822-2150, United States
Pinnacle Health System
Harrisburg, Pennsylvania, 10016, United States
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
Allegheny General Hospital - ASRI
Pittsburgh, Pennsylvania, 15212, United States
Donald Guthrie Foundation for Education and Research
Sayre, Pennsylvania, 18840, United States
Texas Cardiac Arrhythmia
Austin, Texas, 78705, United States
The Methodist Hospital
Houston, Texas, 77030, United States
University of Vermont College of Medicine
Burlington, Vermont, 05405-0068, United States
St. Joseph Medical Center
Tacoma, Washington, 98405, United States
The Northern Hospital
Epping, Victoria, 3076, Australia
Mulgrave Private Hospital
Mulgrave, Victoria, 3170, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
Universitätsklinik Graz
Graz, Styria, 8036, Austria
QE II Health Sciences
Halifax, Nova Scotia, B3H 3A7, Canada
CHUS Fleurimont
Sherbrooke, Styria, 8036, Canada
Fakultni nemocnice Kralovske Vinohrady
Prague, Central Bohemia, 100 34, Czechia
CHRU Rouen Hospital Charles Nicolle
Rouen, Upper Normandy, 76031, France
Clinique Ambroise Pare
Neuilly-sur-Seine, Île-de-France Region, 92200, France
Herzzentrum Leipzig GmbH
Leipzig, Saxony, 04286, Germany
Herz-und Diabetes Zentrum NRW
Bad Oeynhausen, 32545, Germany
Prince of Wales Hospital
Hong Kong, Hong Kong SAR, 999077, Hong Kong
Fortis Memorial Research Institute
Gurugramam, Haryana, 122002, India
Asian Institute of Gastroenterology (AIG) Hospital
Hyderabad, 500032, India
Ospedale Generale Regionale F. Miulli
Acquaviva delle Fonti, 70021, Italy
Ospedale S.Maria della Misericordia
Rovigo, 45100, Italy
Maastricht University Medical Center
Maastricht, 6229 HX, Netherlands
Gornoslaskie Centrum Medyczne im.prof. Leszka Gieca
Katowice, 40-635, Poland
National Heart Centre Singapore
Singapore, Central, 169609, Singapore
NG Teng Fong General Hospital
Singapore, Central, 609606, Singapore
Christiaan Barnard Memorial Hospital
Cape Town, 8001, South Africa
Hospital Universitario Virgen de la Nieves
Granada, 18014, Spain
Hospital General Juan Ramon Jimenez
Huelva, 21005, Spain
Center Inselspital Bern
Bern, 3010, Switzerland
Related Publications (1)
Vazquez PM, Mohamed U, Zanon F, Lustgarten DL, Atwater B, Whinnett ZI, Curila K, Dinerman J, Molina-Lerma M, Wiley J, Grammatico A, Lee K, Vijayaraman P. Result of the Physiologic Pacing Registry, an international multicenter prospective observational study of conduction system pacing. Heart Rhythm. 2023 Dec;20(12):1617-1625. doi: 10.1016/j.hrthm.2023.06.006. Epub 2023 Jun 20.
PMID: 37348800DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kwangdeok Lee
- Organization
- Abbott
Study Officials
- STUDY DIRECTOR
Kwangdeok Lee
Abbott
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2018
First Posted
October 25, 2018
Study Start
November 27, 2018
Primary Completion
October 7, 2021
Study Completion
October 7, 2021
Last Updated
August 19, 2024
Results First Posted
August 19, 2024
Record last verified: 2024-08